[1]SHEN C,TANNENBAUM D,HORN R.Overall survival in phase 3 clinical trials and the surveillance,epidemiology,and end results database in patients with metastatic colorectal cancer,1986-2016:A systematic review[J].JAMA Netw Open,2022,5(5):e2213588.
[2]KISHIKI T,MASAKI T,MATSUOKA H,et al.Modified Glasgow prognostic score in patients with incurable stage Ⅳ colorectal cancer[J].Am J Surg,2013,206(2):234-240.
[3]HASSEN HY,HUSSIEN FM,HASSEN AM,et al.Survival pattern of colorectal cancer in Sub-Saharan Africa:A systematic review and meta-analysis[J].Cancer Epidemiol,2022,81:102276.
[4]WU Z,JU Q.Non-coding RNAs implicated in the tumor microenvironment of colorectal cancer:Roles,mechanisms and clinical study[J].Front Oncol,2022,12:888276.
[5]LU L,HUANG J,MO J,et al.Exosomal lncRNA TUG1 from cancer-associated fibroblasts promotes liver cancer cell migration,invasion,and glycolysis by regulating the miR-524-5p/SIX1 axis[J].Cell Mol Biol Lett,2022,27(1):17.
[6]LIU H,WANG SS,GUAN JZ,et al.Regulatory effect and mechanism of the long non-coding RNA TUG1 on the proliferation,apoptosis,and migration of lung cancer cells[J].Asian J Surg,2022,45(6):1338-1340.
[7]LIU SC,SUN QZ,QIAO XF.LncRNA TUG1 influences osteoblast proliferation and differentiation through the Wnt/β-catenin signaling pathway[J].Eur Rev Med Pharmacol Sci,2019,23(11):4584.
[8]XIE Y,HAN J,XIE K,et al.LncRNAs as biomarkers for predicting radioresistance and survival in cancer:a meta-analysis[J].Sci Rep,2022,12(1):18494.
[9]LI J,ZHANG Y,XU Q,et al.Diagnostic value of circulating lncRNAs for gastric cancer:A systematic review and meta-analysis[J].Front Oncol,2022,12:1058028.
[10]LI H,TIAN G,TIAN F,et al.Long non-coding RNA TUG1 promotes osteosarcoma cell proliferation and invasion through inhibition of microRNA-212-3p expression[J].Exp Ther Med,2022,23(4):280.
[11]SUN J,ZHOU H,BAO X.lncRNA TUG1 facilitates colorectal cancer stem cell characteristics and chemoresistance by enhancing GATA6 protein stability[J].Stem Cells Int,2021,2021:1075481.
[12]SHARMA U,MURMU M,BARWAL TS,et al.A pleiotropic role of long non-coding RNAs in the modulation of Wnt/β-catenin and PI3K/Akt/mTOR signaling pathways in esophageal squamous cell carcinoma:Implication in chemotherapeutic drug response[J].Curr Oncol,2022,29(4):2326-2349.
[13]FU L,WANG Z,JIANG F,et al.High Expression of EIF4G2 mediated by the TUG1/Hsa-miR-26a-5p axis is associated with poor prognosis and immune infiltration of gastric cancer[J].J Oncol,2022,2022:9342283.
[14]YUAN JB,GU L,CHEN L,et al.Annexin A8 regulated by lncRNA-TUG1/miR-140-3p axis promotes bladder cancer progression and metastasis[J].Mol Ther Oncolytics,2021,22:36-51.
[15]JIN Y,CAO J,HU X,et al.Long noncoding RNA TUG1 upregulates VEGFA to enhance malignant behaviors in stomach adenocarcinoma by sponging miR-29c-3p[J].J Clin Lab Anal,2021,35(12):e24106.
[16]ZHAO L,SUN H,KONG H,et al.The lncRNA-TUG1/EZH2 axis promotes pancreatic cancer cell proliferation,migration and EMT phenotype formation through sponging miR-382[J].Cell Physiol Biochem,2017,42(6):2145-2158.
[17]LI W,GE J,XIE J,et al.LncRNA TUG1 promotes hepatocellular carcinoma migration and invasion via targeting the miR-137/AKT2 axis[J].Cancer Biother Radiopharm,2021,36(10):850-862.
[18]YU J,WANG Y,PENG S.The high expression of lncRNA TUG1 correlates with progressive tumor condition and less satisfying survival profiles in prostate cancer patients[J].Transl Cancer Res,2019,8(5):1817-1825.
[19]HAO WY,GUO LW,LUO J,et al.LncRNA TUG1 promotes growth and metastasis of cholangiocarcinoma cells by inhibiting miR-29a[J].Cancer Manag Res,2020,12:11103-11111.
[20]LIU S,LIU Y,LU Q,et al.The lncRNA TUG1 promotes epithelial ovarian cancer cell proliferation and invasion via the WNT/β-catenin pathway[J].Onco Targets Ther,2018,11:6845-6851.
[21]JIN G,YANG Y,TUO G,et al.LncRNA TUG1 promotes tumor growth and metastasis of esophageal squamous cell carcinoma by regulating XBP1 via competitively binding to miR-498[J].Neoplasma,2020,67(4):751-761.
[22]WANG L,ZHONG Q,FENG Y,et al.Long noncoding RNA TUG1 is downregulated in sepsis and may sponge miR-27a to downregulate tumor necrosis factor-α[J].J Int Med Res,2020,48(4):300060520910638.